A Study of exoASO-STAT6 (CDK-004) in Patients With Advanced Hepatocellular Carcinoma (HCC) and Patients With Liver Metastases From EIther Primary Gastric Cancer or Colorectal Cancer (CRC)

NCT05375604 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

9

Enrollment

INDUSTRY

Sponsor class

Stopped Company Bankruptcy

Conditions

Advanced Hepatocellular Carcinoma (HCC)
Gastric Cancer Metastatic to Liver
Colorectal Cancer Metastatic to Liver

Interventions

DRUG: CDK-004

Sponsor

Codiak BioSciences